Tenet Healthcare Corporation $THC is Cambria Investment Management L.P.’s 7th Largest Position

Cambria Investment Management L.P. lessened its holdings in Tenet Healthcare Corporation (NYSE:THC) by 6.3% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 73,883 shares of the company’s stock after selling 4,956 shares during the quarter. Tenet Healthcare accounts for 0.9% of Cambria Investment Management L.P.’s investment portfolio, making the stock its 7th biggest position. Cambria Investment Management L.P. owned 0.08% of Tenet Healthcare worth $15,001,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of THC. CIBC Bancorp USA Inc. bought a new stake in shares of Tenet Healthcare in the 3rd quarter valued at about $1,072,000. Ariadne Wealth Management LP purchased a new position in Tenet Healthcare in the 3rd quarter worth approximately $211,000. Caerus Investment Advisors LLC bought a new stake in Tenet Healthcare in the third quarter valued at approximately $346,000. Captrust Financial Advisors boosted its stake in shares of Tenet Healthcare by 67.4% during the third quarter. Captrust Financial Advisors now owns 10,599 shares of the company’s stock valued at $2,152,000 after purchasing an additional 4,268 shares during the period. Finally, Coldstream Capital Management Inc. grew its holdings in shares of Tenet Healthcare by 6.1% in the third quarter. Coldstream Capital Management Inc. now owns 3,843 shares of the company’s stock worth $780,000 after purchasing an additional 221 shares during the last quarter. 95.44% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Tenet Healthcare news, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the firm’s stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the transaction, the executive vice president directly owned 29,291 shares of the company’s stock, valued at $6,983,853.13. This represents a 18.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 46,517 shares of company stock valued at $10,943,111 over the last ninety days. Company insiders own 0.81% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on THC shares. Cantor Fitzgerald reiterated an “overweight” rating on shares of Tenet Healthcare in a report on Wednesday, March 4th. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Wells Fargo & Company reiterated an “overweight” rating and set a $265.00 target price on shares of Tenet Healthcare in a report on Monday, February 16th. Royal Bank Of Canada boosted their price target on Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a report on Thursday, February 12th. Finally, Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a report on Sunday, March 1st. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $250.56.

Tenet Healthcare Trading Down 3.4%

Shares of THC opened at $211.88 on Wednesday. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $247.21. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. The firm’s 50-day moving average price is $213.78 and its 200-day moving average price is $204.75. The firm has a market capitalization of $18.42 billion, a price-to-earnings ratio of 13.68, a PEG ratio of 1.06 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company had revenue of $5.53 billion during the quarter, compared to the consensus estimate of $5.47 billion. During the same period in the prior year, the firm earned $3.44 earnings per share. Tenet Healthcare’s revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.